Approved Products

Through partnerships with the world's leading biopharmaceutical companies, Nektar has enabled highly successful products in a number of therapeutic areas that are used by medical professionals and patients across the globe.

Products	Status	Indication	Partner	Therapeutic Area
OMONTYS® (peginesatide)	Approved U.S.	Anemia in chronic kidney disease (CKD)		Nephrology
Cimzia®	Approved in U.S.	Crohn's disease Rheumatoid Arthritis		Immunology
MIRCERA®	Approved in EU/U.S.	Anemia in chronic kidney disease (CKD)		Nephrology
Neulasta®	Approved	Neutropenia		Oncology
PEGASYS®	Approved	Hepatitis C		Immunology
PEG-INTRON®	Approved	Hepatitis C		Immunology
DEFINITY® Vial	Approved	Diagnostic		Surgical/Imaging
DuraSeal®	Approved	Cranial Durant Sealant		Surgical/Imaging
Somavert®	Approved	Acromegaly		Immunology
Macugen®	Approved	Wet age-related macular degeneration		Ocular